{"denoms":[{"counts":[{"groupId":"BG000","value":"864"},{"groupId":"BG001","value":"864"},{"groupId":"BG002","value":"862"},{"groupId":"BG003","value":"861"},{"groupId":"BG004","value":"861"},{"groupId":"BG005","value":"4312"}],"units":"Participants"}],"groups":[{"description":"Carboplatin AUC 6 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 8 cycles","id":"BG000","title":"Carbo/Taxol"},{"description":"Carboplatin AUC 5 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 8 cycles plus Gemcitabine 800 mg/m2/dIV on days 1 and 8 x 8 cycles","id":"BG001","title":"Carbo/Taxol/Gemcitabine"},{"description":"Carboplatin AUC 5 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 8 cycles plus Doxil 30 mg/m2 IV every other cycle on day 1 x 8 cycles","id":"BG002","title":"Carbo/Taxol/Doxil"},{"description":"Topotecan 1.25 mg/m2/dIV days 1-3 plus Carboplatin AUC 5 IV on day 3 plus x 4 cycles followed by Carboplatin AUC 6 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 4 cycles","id":"BG003","title":"Carbo/Topotecan - Carbo/Taxol"},{"description":"Gemcitabine 1000 mg/m2/dIV on days 1 and 8 plus Carboplatin AUC 6 IV on day 8 plus x 4 cycles followed by Carboplatin AUC 6 IV on day 1 plus Paclitaxel 175 mg/m2 IV on day 1 x 4 cycles","id":"BG004","title":"Carbo/Gemcitabine - Carbo/Taxol"},{"description":"Total of all reporting groups","id":"BG005","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"11.1","value":"57.8"},{"groupId":"BG001","spread":"10.8","value":"58.8"},{"groupId":"BG002","spread":"11.1","value":"59.0"},{"groupId":"BG003","spread":"11.0","value":"58.2"},{"groupId":"BG004","spread":"10.7","value":"58.9"},{"groupId":"BG005","spread":"10.9","value":"58.6"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"864"},{"groupId":"BG001","value":"864"},{"groupId":"BG002","value":"862"},{"groupId":"BG003","value":"861"},{"groupId":"BG004","value":"861"},{"groupId":"BG005","value":"4312"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"724"},{"groupId":"BG001","value":"749"},{"groupId":"BG002","value":"743"},{"groupId":"BG003","value":"744"},{"groupId":"BG004","value":"721"},{"groupId":"BG005","value":"3681"}]}],"title":"Stage III:see description for details"},{"categories":[{"measurements":[{"groupId":"BG000","value":"140"},{"groupId":"BG001","value":"115"},{"groupId":"BG002","value":"119"},{"groupId":"BG003","value":"117"},{"groupId":"BG004","value":"140"},{"groupId":"BG005","value":"631"}]}],"title":"Stage IV:see description for details"}],"description":"FIGO Staging Classification: 1985.\n\nStage III: Tumor involving one or both ovaries with peritoneal implants outside the pelvis and/or positive retroperitoneal or inguinal nodes. Superficial liver metastasis equals Stage III. Tumor is limited to the true pelvis but with histologically verified malignant extensions to small bowel or omentum.\n\nStage IV: Growth involving one or both ovaries with distant metastasis. If pleural effusion is present there must be positive cytologic test results to allot a case to Stage IV. Parenchymal liver metastasis equals Stage IV.","paramType":"NUMBER","title":"International Federation of Gynecology and Obstetrics (FIGO) Stage","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"748"},{"groupId":"BG001","value":"752"},{"groupId":"BG002","value":"737"},{"groupId":"BG003","value":"752"},{"groupId":"BG004","value":"751"},{"groupId":"BG005","value":"3740"}]}],"title":"Ovary"},{"categories":[{"measurements":[{"groupId":"BG000","value":"116"},{"groupId":"BG001","value":"112"},{"groupId":"BG002","value":"125"},{"groupId":"BG003","value":"109"},{"groupId":"BG004","value":"110"},{"groupId":"BG005","value":"572"}]}],"title":"Peritoneum"}],"paramType":"NUMBER","title":"Primary Site of Disease","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"197"},{"groupId":"BG001","value":"218"},{"groupId":"BG002","value":"206"},{"groupId":"BG003","value":"220"},{"groupId":"BG004","value":"203"},{"groupId":"BG005","value":"1044"}]}],"title":"Microscopic only"},{"categories":[{"measurements":[{"groupId":"BG000","value":"404"},{"groupId":"BG001","value":"384"},{"groupId":"BG002","value":"405"},{"groupId":"BG003","value":"358"},{"groupId":"BG004","value":"398"},{"groupId":"BG005","value":"1949"}]}],"title":"≤ 1 cm gross disease"},{"categories":[{"measurements":[{"groupId":"BG000","value":"263"},{"groupId":"BG001","value":"262"},{"groupId":"BG002","value":"251"},{"groupId":"BG003","value":"283"},{"groupId":"BG004","value":"260"},{"groupId":"BG005","value":"1319"}]}],"title":"> 1 cm gross disease"}],"paramType":"NUMBER","title":"Size of Residual Disease","unitOfMeasure":"participants"}]}